Evidence map›Paper›PMID 41550968›Full record

ArticleFood science & nutrition2026

Fuc-S, a New Degraded Polysaccharide From Fucoidan, Alleviates Type 2 Diabetes-Associated Liver Injury Through Modulating Gut Microbiota.

Bin Du, Caihong Cheng, Jinxiu Feng, Yue Liang, Wang Tao, Baojun Xu, Jiao Peng, Guangtao Zhang, Yuedong Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food science & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bin DuHebei Key Laboratory of Natural Products Activity Components and Function Hebei Normal University of Science and Technology Qinhuangdao China.ORCID https://orcid.org/0000-0003-2146-5854
Caihong ChengHebei Key Laboratory of Natural Products Activity Components and Function Hebei Normal University of Science and Technology Qinhuangdao China.ORCID https://orcid.org/0000-0002-0003-2630
Jinxiu FengHebei Key Laboratory of Natural Products Activity Components and Function Hebei Normal University of Science and Technology Qinhuangdao China.
Yue LiangDepartment of Pharmacy Peking University Shenzhen Hospital Shenzhen Guangdong China.
Wang TaoDepartment of Pharmacy Peking University Shenzhen Hospital Shenzhen Guangdong China.
Baojun XuFood Science and Technology Program, Department of Life Sciences Beijing Normal-Hong Kong Baptist University Zhuhai China.ORCID https://orcid.org/0000-0003-0739-3735
Jiao PengDepartment of Pharmacy Peking University Shenzhen Hospital Shenzhen Guangdong China.
Guangtao ZhangDepartment of Hepatobiliary and Pancreatic Surgery Peking University Shenzhen Hospital Shenzhen Guangdong China.
Yuedong YangHebei Key Laboratory of Natural Products Activity Components and Function Hebei Normal University of Science and Technology Qinhuangdao China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is frequently associated with liver injury. This study examines the therapeutic potential of

Indexed as

fucoidangut microbiotaliver injurymetabolitesT2DM

Identifiers

PMID41550968
PMCPMC12809177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.